Pasar al contenido principal

LOS ADN EN G-CUADRUPLEX COMO DIANA TERAPEUTICA EN ONCOLOGIA Y EN ENFERMEDADES INFECCIOSAS: DISEÑO, SINTESIS Y EVALUACION DE LIGANDOS COMO POTENCIALES FARMACOS

PID2021-127109OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Probing the binding and antiparasitic efficacy of azobenzene G-quadruplex ligands to investigate G4 ligand design

  • Ramos-Soriano, Javier
  • Holbrow-Wilshaw, Maisie
  • Hunt, Eliza
  • Jiang, Y. Jennifer
  • Peñalver, Pablo
  • Morales, Juan Carlos
  • Galán, M. Carmen
This article is part of the themed collection: ChemComm 60th Anniversary Collection., Novel strategies against parasitic infections are of great importance. Here, we describe a G4 DNA ligand with subnanomolar antiparasitic activity against T. brucei and a remarkable selectivity index (IC50 MRC-5/T. brucei) of 2285-fold. We also correlate the impact of small structural changes to G4 binding activity and antiparasitic activity., MCG thanks ERC-COG: 648239, J. R.-S. thanks MSCA fellowship (project 843720-BioNanoProbes). E. H. thanks EPSRC EP/L015366/1 and J. Y. J. (EPSRC EP/L015366/1 and EP/S026215/1) for their PhD studentships. JCM thanks the Spanish Ministerio de Ciencia, Innovación y Universidades (Grant PID2021-127109OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

DNA G-quadruplexes in the genome of Trypanosoma cruzi as potential therapeutic targets for Chagas disease: Dithienylethene ligands as effective antiparasitic agents

  • Pérez Soto, Manuel
  • Ramos-Soriano, Javier
  • Peñalver, Pablo
  • Belmonte-Reche, Efres
  • O'Hagan, Michael P.
  • Cucchiarini, Anne
  • Mergny, Jean-Louis
  • Galán, M. Carmen
  • López López, Manuel Carlos
  • Thomas, María del Carmen
  • Morales, Juan Carlos
Chagas disease is caused by the parasite Trypanosoma cruzi and affects over 7 million people worldwide. The two actual treatments, Benznidazole (Bzn) and Nifurtimox, cause serious side effects due to their high toxicity leading to treatment abandonment by the patients. In this work, we propose DNA G-quadruplexes (G4) as potential therapeutic targets for this infectious disease. We have found 174 PQS per 100,000 nucleotides in the genome of T. cruzi and confirmed G4 formation of three frequent motifs. We synthesized a family of 14 quadruplex ligands based in the dithienylethene (DTE) scaffold and demonstrated their binding to these identified G4 sequences. Several DTE derivatives exhibited micromolar activity against epimastigotes of four different strains of T. cruzi, in the same concentration range as Bzn. Compounds L3 and L4 presented remarkable activity against trypomastigotes, the active form in blood, of T. cruzi SOL strain (IC50 = 1.5-3.3 μM, SI = 25-40.9), being around 40 times more active than Bzn and displaying much better selectivity indexes., JCM thanks the funding by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-127109OB-I00). EBR received funding support from a Maria Zambrano fellowship, financed by NextGenerationEU/European Union. MCG thanks ERC-COG: 648239, EPSRC Funds EP/R043361/1, TS/R014329/1 and GCRF EP/T020288/1 for financial support and JRS thanks MSCA fellowship (project 843720-BioNanoProbes). A.C. and J.L.M. thank the generous benefactors of the Fondation X for their support. MCL and MCT were supported by grant PID2019-109090RB-I00/AEI/10.13039/501100011033 from the Programa Estatal I + D + I, Spanish Ministry of Science, Innovation and Universities (MICINN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oligostyrylbenzene Derivatives with Antiparasitic and Antibacterial Activity as Potent G-Quadruplex Ligands

  • Pérez Soto, Manuel
  • Peñalver, Pablo
  • Muñoz-Báez, Paloma
  • Tolosa, Juan
  • García-Martínez, Joaquín Calixto
  • Cebrián, Rubén
  • Morales, Juan Carlos
G-quadruplexes (G4s) are non-canonical secondary structures that play a crucial role in the regulation of genetic expression. This study explores the interaction between G4s and a small family of oligostyrylbenzene (OSB) derivatives, characterized by tris(styryl)benzene and tetrastyrylbenzene backbones, functionalized with either trimethylammonium or 1-methylpyridinium groups. Initially identified as DNA ligands, these OSB derivatives have now been recognized as potent G4 binders, surpassing in binding affinity commercially available ligands such as pyridostatin and displaying good selectivity for G4s over duplex DNA. Furthermore, OSB derivatives 1 and 2 demonstrated significant antiparasitic activity against bloodstream forms of T. brucei and extracellular L. major, with high selectivity indices when compared to MRC-5 healthy control cells. Derivatives 1 and 2 exhibited moderate biocidal effects against a range of Gram-positive and Gram-negative bacterial strains. Notably, a synergistic antibacterial effect was observed when these compounds were combined with traditional antibiotics, particularly against Acinetobacter baumannii, highlighting their potential utility in addressing drug-resistant bacterial infections. The differences in bioactivity among the OSB derivatives can be attributed to variations in cellular uptake, as proved by flow cytometry analysis. This suggests that the degree of cellular internalization plays a pivotal role in the observed antiparasitic and antibacterial efficacy., J.C.M. gives thanks for the funding provided by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-127109OB-I00). R.C. and P.M.B. are supported by the Instituto de Salud Carlos III (ISCIII), Miguel Servet (ref: CP21/00113) and P-FIS (ref: FI23/00036) programs, respectively. J.T. and J.C.G.M. thank Junta de Comunidades de Castilla-La Mancha (SBPLY/21/180501/000042) and Universidad de Castilla-La Mancha (2022-GRIN-34214)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Beyond antiparasitic activity: elucidating the antibacterial potency of pyrvinium pamoate

  • Alcaraz-Martínez, Angela
  • Muñoz-Báez, Paloma
  • Peñalver, Pablo
  • Morales, Juan Carlos
  • Cebrián, Rubén
Antimicrobial resistance represents a critical global health threat, demanding innovative therapeutic strategies. In this study, we investigate the repurposing potential of pyrvinium pamoate (PP)-a long-established anthelmintic agent-for antibacterial applications. Comprehensive in vitro analyses revealed that while gram-negative bacteria exhibited inherent resistance due to limited drug uptake, gram-positive pathogens, particularly within the orders Actinomycetales and Bacillales, were markedly susceptible at low micromolar concentrations. Enhanced antibacterial efficacy was observed when PP was combined with outer membrane-permeabilizing agents, such as the peptide D11 or pentamidine, which facilitated increased intracellular accumulation. Additionally, the role of efflux pump activity was explored; its inhibition in Staphylococcus aureus resulted in significant drug retention and a concomitant reduction in minimum inhibitory concentrations, while disruption of the proton motive force attenuated uptake. The compound demonstrated bactericidal effects against S. aureus and a bacteriostatic profile against Pseudomonas aeruginosa when sensitized with outer membrane permeabilizing agents. Furthermore, synergistic studies with several antibiotics revealed the potential of PP as a valuable addition to the antimicrobial arsenal against multidrug-resistant pathogens. These findings motivate further mechanistic studies and clinical evaluation of PP in antimicrobial therapy. PP shows promise as a repurposed antibacterial agent, particularly against gram-positive pathogens, with enhanced activity against gram-negative pathogens when combined with membrane-permeabilizing agents or in the presence of efflux pump inhibitors., R.C. is funded by the Instituto de Salud Carlos III (ISCIII) through the project "CP21/00113" and co-funded by the European Union. P.M.-B. by a PFIS grant (FI23/00036) from the same institution. This study has also been co-funded by the project PI-0220-2024 from the Consejería de Salud y Consumo (Junta de Andalucía) and the project MP_P03_2024 from the ibs.GRANADA. J.C.M. and P.P. thank the Spanish Ministry of Science, Innovation and Universities for funding (PID2021-127109OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Extending Thioflavin T Fluorescence Probe to 2-Ethenyl-benzothiazole Derivatives: Drug-like Quadruplex Ligands with Potent Antitrypanosomatid Activity

  • Gonçalves, Raquel C. R.
  • Peñalver, Pablo
  • Allen, Nina M.
  • Belmonte-Reche, Efres
  • García-Pérez, Belén
  • Costa, Susana P. G.
  • Jiang, Y. Jennifer
  • Pérez-Victoria, José M.
  • Galán, M. Carmen
  • Raposo, María Manuela M.
  • Morales, Juan Carlos
Thioflavin T (ThT) is a well-established fluorescence probe with selectivity for G-quadruplex (G4) structures. Over the past few years, G4 ligands have emerged as promising candidates for the development of antiparasitic agents. Building on this concept, we explored extending ThT's benzothiazole scaffold by introducing various 2-ethenyl aromatic and heteroaromatic moieties, aiming to enhance G4 binding affinity and potential therapeutic effect. A series of benzothiazolium derivatives were synthesized and evaluated for their antiproliferative and antiparasitic activity. Several 2-ethenyl benzothiazole derivatives showed submicromolar activity against Leishmania spp. and Trypanosoma brucei parasites, with up to 200-fold selectivity over MRC-5 human lung fibroblasts. Notably, compound 2b demonstrated remarkable potency, with an IC50 of 0.48 nM and a selectivity index of 46,151 against Leishmania major amastigotes, and an IC50 of 0.019 nM and a selectivity index of 79,206 against T. brucei. In fact, compound 2b demonstrated superior efficacy and selectivity in comparison to the clinically used drugs suramin, fexinidazole, miltefosine, and amphotericin B. Biophysical studies revealed that all tested derivatives exhibited significant G4 stabilization, surpassing ThT. Location of compound 2b inside the nucleus and the kinetoplast, as well as partially in the mitochondria, opens up the possibility of 2b acting against the parasite through binding to G4., J.C.M. and J.M.P.V. thanks the funding by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-127109OB-I00 and PID2022-138474OB-I00, respectively). EBR received funding support from a Maria Zambrano fellowship, financed by NextGenerationEU/European Union. MCG thanks ERC-COG: 648239, EPSRC TECS CDT EP/S024107/1, EPSRC CDT EP/L015366/1 and GCRF EP/T020288/1 for financial support. B.G.P. acknowledges the financial support from the Spanish Ministry of Universities through an FPU predoctoral fellowship (FPU22/04095). This work was also supported by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UID/00686: Centro de Química da Universidade do Minho (CQ-UM), and a PhD grant to R.C.R. Gonçalves (SFRH/BD/05278/2020, 10.54499/2020.05278.BD). The NMR spectrometer Bruker Avance III 400 is part of the National NMR Network and was purchased within the framework of the National Program for Scientific Re-equipment, contract REDE/1517/RMN/2005 with funds from POCI 2010 (FEDER) and FCT., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

G-quadruplexes as antimicrobial targets

  • Cebrián, Rubén
  • Morales, Juan Carlos
Escalating antibiotic resistance and poor options for many parasitic infections, including neglected tropical diseases, demand new antimicrobial strategies. G-quadruplexes (G4s), which are noncanonical nucleic acid structures, are emerging targets in microbial genomes. We summarize evidence for G4 formation in bacteria and parasites, which is provided by phenotypic and chemical-biology datasets, whereas evidence in support of fungal G4 targeting remains nascent, with fewer studies and limited mechanistic validation. After integrating genomics and bioinformatics data, we argue that microbial G4s are a promising yet incompletely validated target class, backed by expanding catalogues of putative G4-forming loci and ligand-associated phenotypes. For many reported ligands, however, direct intracellular G4 engagement and causal links to the killing or growth inhibition of microbes are still unproven. We discuss ligand chemotypes, design principles, and pharmacological considerations in the translation of G4s into therapeutics., R.C. is funded by the Instituto de Salud Carlos III (ISCIII) through the project CP21/00113 and co-funded by the European Union. This study has also been co-funded by the project PI-0220-2024 from the Consejería de Salud y Consumo (Junta de Andalucía) and the project MP_P03_2024 from the ibs. GRANADA. J.C.M. thanks the Spanish Ministry of Science, Innovation and Universities for funding (PID2021-127109OB-I00 and PID2024-158343OB-I00)., Peer reviewed